Showing results (91-100 of 537) with videos related to
Sort By:
Pageof 54
Proteomics. Clinical Applications|December 8, 2010
Simultaneous metabolic labeling of cells with multiple amino acids: Localization and dynamics of histone acetylation and methylationChen Ren, Shujun Liu, Kalpana Ghoshal, et al.International Journal of Pharmaceutics|October 2, 2010
Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acidHong Li, Yanhui Lu, Longzhu Piao, et al.Nature Communications|February 4, 2026
Human type-1 innate lymphoid cells control leukemia stem cell differentiation and limit acute myeloid leukemia developmentZhenlong Li, Rui Ma, Hejun Tang, et al.Journal of Proteome Research|January 6, 2007
Histone H4 N-terminal acetylation in Kasumi-1 cells treated with depsipeptide determined by acetic acid-urea polyacrylamide gel electrophoresis, amino acid coded mass tagging, and mass spectrometryLiwen Zhang, Xiaodan Su, Shujun Liu, et al.Hematological Oncology|November 12, 2021
Immunophenotype of acute lymphoblastic leukemia in minorities- analysis from the SEER databaseElisa Quiroz, Aparajit Ram Venkateswaran, Rebecca Nelson, et al.The Journal of Biological Chemistry|April 26, 2011
Purification, identification, and cloning of lysoplasmalogenase, the enzyme that catalyzes hydrolysis of the vinyl ether bond of lysoplasmalogenLai-Chu Wu, Douglas R Pfeiffer, Elisabeth A Calhoon, et al.Leukemia Research|June 25, 2017
Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemiaBijender Kumar, Arjun Kalvala, Su Chu, et al.Journal of the American Society for Mass Spectrometry|December 31, 2003
Differential expression of histone post-translational modifications in acute myeloid and chronic lymphocytic leukemia determined by high-pressure liquid chromatography and mass spectrometryLiwen Zhang, Michael A Freitas, Joseph Wickham, et al.American Journal of Hematology|August 11, 2020
A phase I study of lenalidomide plus chemotherapy with idarubicin and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndromeCaner Saygin, Karilyn Larkin, James S Blachly, et al.Blood|December 18, 2007
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemiaShujun Liu, Zhongfa Liu, Zhiliang Xie, et al.Pageof 54